A Research Study Investigating How Semaglutide and Dapagliflozin Act in Your Body When Dosed in One Tablet

PHASE1CompletedINTERVENTIONAL

Enrollment

152

Participants

Timeline

Start Date

June 22, 2022

Primary Completion Date

March 10, 2023

Study Completion Date

April 13, 2023

Conditions

Healthy Volunteers

Interventions

DRUG

Semaglutide

Tablet given orally

DRUG

Dapagliflozin

Tablet given orally

DRUG

Semaglutide/dapagliflozin

Tablet given orally

Trial Locations (2)

Novo Nordisk Investigational Site, Berlin

Parexel International GmbH, Berlin